Skip to content
healthcare.dev

Hydralazine Hydrochloride

NDC 71610-549, Hydralazine Hydrochloride, tablet, from Aphena Pharma Solutions - Tennessee, LLC.

Product NDC
71610-549
Status
Listed
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205236
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71610-549 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDRALAZINE HYDROCHLORIDE100 mg/1

Pharmacologic classes

Arteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]

Package NDCNDC-11Package
71610-549-02716100549022000 TABLET in 1 BOTTLE (71610-549-02)
71610-549-05716100549054200 TABLET in 1 BOTTLE (71610-549-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c2638ae6-a210-490f-8389-bbed6a3229c5

Use it

Look up 71610-549 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71610-549 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71610-549. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.